![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, September 09, 2013 3:11:51 PM
"What a kick in the coin purse. MT pretty much killed any hope for the Sept 14th presentation and all hopes that CLSN would have the data to go to the FDA or SFDA for that matter. Announcing another trial starting next year puts CLSN on the shelf for at least 3yrs. The dream is over but is not dead. I just wish I could take a 3yr nap and wake up to a blockbuster stock. With today's presentation we will see sub $1. I hate to admit it but CLSN is no closer than if they never ran a Heat study except they discovered that dwell time improves Thermodox and abalation vs abalation alone. How did they miss that in the first protocol for phase 3. It seems the Dignity trial was a smokescreen to soften the blow for announcing new Heat trial with longer durations. Very sad day for longs like myself that thought CLSN had some meat on the bone for chances of using sub group for approval in China. No mention of HINSUN agreement, nothing positive, we are dead in the water for years. If possible please convince me otherwise.... Not sure how u could."
It's tough to refute the cold facts. Can anyone?
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM